Auto-generated event page

Allogene Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update

SOUTH SAN FRANCISCO, Calif., March 02, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of ...

Score 47 medium confidence 3 source posts Updated Mar 2, 2026, 1:46 PM UTC

Track This Event Open Event in App More Signal Pages

Cluster sources

Newest source rows first.

Allogene Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update

GlobeNewswire Public Companies • Mar 2, 2026, 1:30 PM UTC

Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

GlobeNewswire Earnings Releases and Operating Results • Mar 2, 2026, 12:30 PM UTC

Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire Earnings Releases and Operating Results • Mar 2, 2026, 12:00 PM UTC

Entity focus

Direct link to post

https://pushme.site/signals/172558-allogene-therapeutics-to-report-fourth-quarter-and-full-year-2025-financ?utm_source=signal-172558&utm_medium=social&utm_campaign=signal-pages&utm_content=hero

Quick distribution loop

Step 1

Post this live link in threads where users ask how to monitor this event.

Step 2

Point readers to "Track This Event" for immediate conversion into an alert.

Step 3

Reuse entity keywords from this page for targeted follow-up replies.

Back to signal pages Open query hub